Skip to Content
Merck
CN
  • A low-toxicity method for the separation of lanosterol and dihydrolanosterol from commercial mixtures.

A low-toxicity method for the separation of lanosterol and dihydrolanosterol from commercial mixtures.

Steroids (2004-10-07)
Levan K Kavtaradze, Merilyn Manley-Harris, Brian K Nicholson
ABSTRACT

We describe an inexpensive, low-toxicity and high-yielding method for the production of pure lanosterol and dihydrolanosterol from the commercially available mixture. Optimum conditions are presented for the one-pot production of the intermediate 24,25 vicinal diol of lanosterol acetate (via either epoxidation or hydroxyhalogenation) which is readily separated from the unreacted dihydrolanosterol acetate. The lanosterol diol can then be converted to pure (>97%) lanosterol. Hypophosphorous acid was used for both the conversion of the epoxide to the diol, and as a catalyst for the hydroxyhalogenation by N-halosuccinimides of the olefinic bond.

MATERIALS
Product Number
Brand
Product Description

Avanti
dihydrolanosterol-d7, Avanti Research - A Croda Brand